Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400085129Phase 4Not yet recruiting
Phase 4, open-label trial of remimazolam in Perioperative anxiety (2 arms), sponsored by Fuyang Hospital of Anhui Medical University. Primary endpoint: State-Trait Anxiety Inventory score. Planned start May 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400085129.